Successful use of flecainide in atrial fibrillation with rapid ventricular rate in the Wolff-Parkinson-White syndrome
- 30 June 1988
- journal article
- case report
- Published by Elsevier in American Heart Journal
- Vol. 115 (6) , 1317-1321
- https://doi.org/10.1016/0002-8703(88)90032-4
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Evaluation of flecainide acetate in rapid atrial fibrillation complicating wolff‐parkinson‐white syndromeClinical Cardiology, 1985
- Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular connections, and pacemaker thresholdsThe American Journal of Cardiology, 1984
- Effects of flecainide on electrophysiological properties of accessory pathways in the Wolff-Parkinson-White syndromeEuropean Heart Journal, 1983
- Onset of atrial fibrillation during antidromic tachycardia: Association with sudden cardiac arrest and ventricular fibrillation in a patient with Wolff-Parkinson-White syndromeThe American Journal of Cardiology, 1982
- Effect of isoproterenol on the anterograde refractory period of the accessory pathway in patients with the Wolff-Parkinson-White syndromeThe American Journal of Cardiology, 1982
- Oral Flecainide Acetate for the Treatment of Ventricular ArrhythmiasNew England Journal of Medicine, 1981
- Effect of drugs in the wolff-parkinson-white syndromeThe American Journal of Cardiology, 1980
- Characterization of Atrial Fibrillation in Man: Studies Following Open Heart Surgery*Pacing and Clinical Electrophysiology, 1978
- Ventricular FibrillationCirculation, 1971
- Refractory Period of the Dog's Ventricular Myocardium Following Sudden Changes in FrequencyCirculation Research, 1969